These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

890 related articles for article (PubMed ID: 17681396)

  • 21. The role of epigenetic alterations in pancreatic cancer.
    Sato N; Goggins M
    J Hepatobiliary Pancreat Surg; 2006; 13(4):286-95. PubMed ID: 16858539
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DNA methylation alterations in multiple myeloma as a model for epigenetic changes in cancer.
    Sharma A; Heuck CJ; Fazzari MJ; Mehta J; Singhal S; Greally JM; Verma A
    Wiley Interdiscip Rev Syst Biol Med; 2010; 2(6):654-69. PubMed ID: 20890963
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel approaches on epigenetics.
    Papait R; Monti E; Bonapace IM
    Curr Opin Drug Discov Devel; 2009 Mar; 12(2):264-75. PubMed ID: 19333872
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Promises and challenges of anticancer drugs that target the epigenome.
    Verbrugge I; Johnstone RW; Bots M
    Epigenomics; 2011 Oct; 3(5):547-65. PubMed ID: 22126246
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Towards targeted epigenetic therapy of cancer.
    Magic Z; Supic G; Brankovic-Magic M
    J BUON; 2009 Sep; 14 Suppl 1():S79-88. PubMed ID: 19785074
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting DNA methylation in cancer.
    Szyf M
    Bull Cancer; 2006 Sep; 93(9):961-72. PubMed ID: 16980240
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Using ChIP-based technologies to identify epigenetic modifications in disease-relevant cells.
    Falk J
    IDrugs; 2010 Mar; 13(3):169-74. PubMed ID: 20191433
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epigenetic tools in potential anticancer therapy.
    Sebova K; Fridrichova I
    Anticancer Drugs; 2010 Jul; 21(6):565-77. PubMed ID: 20436342
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epi-drugs to fight cancer: from chemistry to cancer treatment, the road ahead.
    Mai A; Altucci L
    Int J Biochem Cell Biol; 2009 Jan; 41(1):199-213. PubMed ID: 18790076
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interplay between DNA methylation, histone modification and chromatin remodeling in stem cells and during development.
    Ikegami K; Ohgane J; Tanaka S; Yagi S; Shiota K
    Int J Dev Biol; 2009; 53(2-3):203-14. PubMed ID: 19412882
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Approaches to target the genome and its epigenome in cancer.
    Chapman-Rothe N; Brown R
    Future Med Chem; 2009 Nov; 1(8):1481-95. PubMed ID: 21426061
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epigenetic opportunities and challenges in cancer.
    Best JD; Carey N
    Drug Discov Today; 2010 Jan; 15(1-2):65-70. PubMed ID: 19897050
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epigenomic profiling of cancer cells.
    Gargiulo G; Minucci S
    Int J Biochem Cell Biol; 2009 Jan; 41(1):127-35. PubMed ID: 18771747
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epigenetic changes in virus-associated human cancers.
    Li HP; Leu YW; Chang YS
    Cell Res; 2005 Apr; 15(4):262-71. PubMed ID: 15857581
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [DNA methylation: an epigenetic process of medical importance].
    Rodríguez-Dorantes M; Téllez-Ascencio N; Cerbón MA; López M; Cervantes A
    Rev Invest Clin; 2004; 56(1):56-71. PubMed ID: 15144044
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cancer epigenome.
    Lechner M; Boshoff C; Beck S
    Adv Genet; 2010; 70():247-76. PubMed ID: 20920751
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epigenetic deregulation of DNA repair and its potential for therapy.
    Hegi ME; Sciuscio D; Murat A; Levivier M; Stupp R
    Clin Cancer Res; 2009 Aug; 15(16):5026-31. PubMed ID: 19671858
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The clinical application of targeting cancer through histone acetylation and hypomethylation.
    Gilbert J; Gore SD; Herman JG; Carducci MA
    Clin Cancer Res; 2004 Jul; 10(14):4589-96. PubMed ID: 15269129
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DNA methyltransferase inhibitors and the development of epigenetic cancer therapies.
    Lyko F; Brown R
    J Natl Cancer Inst; 2005 Oct; 97(20):1498-506. PubMed ID: 16234563
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanisms of disease: epigenesis.
    Waggoner D
    Semin Pediatr Neurol; 2007 Mar; 14(1):7-14. PubMed ID: 17331879
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 45.